Executive Summary Tumor Markers Testing Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The market was valued at USD 16.7 billion in 2022 and would grow to USD 30.23 billion by 2030...

Diagnostic Imaging Market Overview The Global Diagnostic Imaging Market size is experiencing robust growth, driven by the increasing prevalence of chronic diseases, rising demand for early and accurate diagnosis, and technological advancements in imaging modalities. According to market analysis, the Diagnostic Imaging Market is projected to grow from USD 50.1 billion in 2025 to USD...

The Fecal Immunochemical Test (FIT) market is experiencing significant growth, driven by the increasing prevalence of colorectal cancer (CRC), advancements in diagnostic technologies, and a global shift towards preventive healthcare. This non-invasive screening method is gaining prominence due to its accuracy, ease of use, and cost-effectiveness. GET REPORT...

Fecal Immunochemical Diagnostic Test (FIT) Market: Driving Early Detection and Shaping Preventive Healthcare The global healthcare industry is undergoing a major shift toward preventive and early diagnostic solutions, and one area gaining significant traction is colorectal cancer screening. Among the most effective tools available, the Fecal Immunochemical Test (FIT) stands out...

The global liquid biopsy market has emerged as one of the most promising segments in molecular diagnostics, driven by advancements in precision medicine and oncology. Valued at USD 11.91 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 11.9% between 2025 and 2034, reaching USD 36.59 billion by 2034. Liquid biopsy, a...

"Executive Summary: Lung Cancer Screening Software Market Size and Share by Application & Industry CAGR Value The global lung cancer screening software market size was valued at USD 47.38 billion in 2024 and is expected to reach USD 195.75 billion by 2032, at a CAGR of 19.40% during the forecast period. In the leading Lung Cancer Screening Software...

Market Overview The global oncology-based molecular diagnostics market is witnessing steady and sustained growth, reflecting the growing role of molecular-level technologies in transforming cancer care. Valued at USD 3.66 billion in 2024, the market is projected to reach USD 6.12 billion by 2034, expanding at a CAGR of 5.3% from 2025 to 2034. This growth...

Executive Summary Thyroid Cancer Diagnostics Market : The global thyroid cancer diagnostics market size was valued at USD 7.50 billion in 2023 and is projected to reach USD 11.69 billion by 2031, with a CAGR of 5.70% during the forecast period of 2024 to 2031 This Thyroid Cancer Diagnostics Market report has several aspects of marketing research and analysis which includes...